Recent developments in oral hypoglycemic agents

Drug Discovery Today

Volumn 4, Issue 6, 1999, Pages 283-288

  Shinkai, Hisashi ^a  

^a JT Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRL 48482; CIGLITAZONE; GLIBENCLAMIDE; GLUCOSE; INSULIN; MEGLITINIDE; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; REGLITAZAR; REPAGLINIDE; ROSIGLITAZONE; SB 213068; THIAZOLIDINE DERIVATIVE; TROGLITAZONE; UNCLASSIFIED DRUG;

CHEMICAL STRUCTURE; DIABETES CONTROL; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

EID: 0032978394     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(99)01331-8     Document Type: Review

References (60)

1. Eschwege E.et al. IDF Bull. 42:1997;14-19.
2. Porte D. Jr.et al. Science. 272:1996;699-700.
3. Clark C.M.et al. New Engl. J. Med. 332:1995;1210.
4. Williams G. Lancet. 343:1994;95-100.
5. Lancet. 352:1998;837-853.
6. Diabetologia. 24:1983;404-411.
7. Berhhard H. Diabetes. 14:1965;59-70.
8. Balodimos M.C.et al. Metabolism. 15:1966;957-970.
9. Powell T.et al. Diabetes. 15:1966;269-275.
10. Diabetes. 34:1985;793-798.
11. Lillioja S.et al. New Engl. J. Med. 329:1993;1988-1992.
12. Fujita T.et al. Diabetes. 32:1983;804-810.
13. Chang A.Y.et al. Diabetes. 32:1983;830-838.
14. Sugiyama Y.et al. Arzneim.-Forsch. Drug Res. 40:1990;263-267.
15. Stevenson R.et al. Diabetes. 39:1990;1218-1227.
16. Yamasaki Y.et al. Tohoku J. Exp. Med. 183:1997;173-183.
17. Patel J.et al. Diabetes. 47:1998;A17.
18. Suter S.L.et al. Diabetes Care. 15:1992;193-203.
19. Ogihara T.et al. Am. J. Hypertens. 8:1995;316-320.
20. Iwamoto Y.et al. Diabetes Care. 19:1996;151-156.
21. Iwamoto Y.et al. Diabetes Care. 14:1991;1083-1086.
22. Nolan J.J.et al. New Engl. J. Med. 331:1994;1188-1193.
23. Antonucci T.et al. Diabetes Care. 20:1997;188-193.
24. Ghazzi M.N.et al. Diabetes. 46:1997;433-439.
25. Johnson M.D.et al. Ann. Pharmacother. 32:1998;337-348.
26. Yoshioka T.et al. J. Med. Chem. 32:1989;421-428.
27. Koenig R.J.et al. New Engl. J. Med. 295:1976;417.
28. Sohda T.et al. Arzneim.-Forsch. Drug Res. 40:1990;37.
29. Lehmann J.M.et al. J. Biol. Chem. 270:1995;12953-12956.
30. Willson T.M.et al. J. Med. Chem. 39:1996;665-668.
31. Sohda T.et al. Chem. Pharm. Bull. 30:1982;3563-3573.
32. Dow R.L.et al. J. Med. Chem. 34:1991;1538-1544.
33. Goldstein S.W.et al. J. Med. Chem. 36:1993;2238-2240.
34. Shinkai H.et al. J. Med. Chem. 41:1998;1927-1933.
35. Hulin B.et al. J. Med. Chem. 39:1996;3897-3907.
36. Buckle D.R.et al. Bioorg. Med. Chem. Lett. 6:1996;2121-2126.
37. Buckle D.R.et al. Bioorg. Med. Chem. Lett. 6:1996;2127-2130.
38. Polonsky K.S.et al. New Engl. J. Med. 318:1988;1231-1239.
39. Schmid-Antomarchi H.S.et al. J. Biol. Chem. 262:1987;15840-15844.
40. Ashcroft S.J.H.et al. Biochim. Biophys. Acta. 1175:1992;45-59.
41. Edwards G.et al. Annu. Rev. Pharmacol. Toxicol. 33:1993;597-637.
42. Panten U.et al. Exp. Clin. Endocrinol. Diabetes. 104:1996;1-9.
43. Asplund K.et al. Diabetologia. 24:1983;412-417.
44. Ferner R.E.et al. Br. Med. J. 296:1988;949-950.
45. Shinkai H.et al. J. Med. Chem. 32:1989;1436-1441.
46. Shinkai H., Sato Y. Bailey C.J., Flatt P.R. New Antidiabetic Drugs. 1987;249-254 Smith-Gordon/Nishimura.
47. Sato Y.et al. Diabetes Res. Clin. Pract. 12:1991;53-60.
48. Akiyoshi M.et al. Am. J. Physiol. 268:1995;E185.
49. Fujitani S.et al. Endocrinology. 134:1944;1395-1400.
50. Ikenoue T.et al. Br. J. Pharmacol. 120:1997;137-145.
51. Kikuchi M. Diabetic Med. 13:1996;S151.
52. Geisen K.et al. Arzneim.-Forsch. Drug Res. 28:1978;1081-1083.
53. Malaisse W.J. Horm. Metab. Res. 21:1995;694-699.
54. Van Onderbergen A.et al. Med. Sci. Res. 23:1995;371.
55. Gromada J.et al. Diabetologia. 38:1995;1025-1032.
56. Fuhlendorff J.et al. Diabetes. 47:1998;345-351.
57. Wang F. Formulary. 33:1998;409-423.
58. Miles P.D.G.et al. Diabetes. 47:1998;395-400.
59. Shinkai H.et al. J. Med. Chem. 41:1998;5420-5428.
60. Sohda T.et al. J. Med. Chem. 35:1992;2617-2626.